Demonstration Formulary
4 Central nervous system
PALLIATIVE CARE PHYSICIANS - Guidelines for the use of drugs in symptom control
04-07-04-02 Prophylaxis of migraine
| Erenumab Aimovig® |
|
Formulary
|
In line with NICE |
 NICE TA682: Erenumab for preventing migraine |
|
| Fremanezumab Ajovy® |
|
Formulary
|
In line with NICE |
|
NICE TA764: Fremanezumab for preventing migraine NICE TA631: Fremanezumab for preventing migraine |
|
|
| Galcanezumab Emgality® |
|
Formulary
|
In line with NICE |
|
NICE TA659: Galcanezumab for preventing migraine |
|
|
| Botulinum Toxin Type A |
|
Formulary
|
For hospital use only Use in line with NICE |
|
NICE TA260: Botox for migraine prophylaxis |
|
|
Links
- Administration of depot antipsychotic injections during COVID-19 in stable adult patients
NICE CG88: Lower back pain- NICE TA260: Botox for migraine prophylaxis
- NICE TA631: Fremanezumab for preventing migraine
- NICE TA659: Galcanezumab for preventing migraine
- NICE TA682: Erenumab for preventing migraine
- NICE TA764: Fremanezumab for preventing migraine
- The CCG’s Nociceptive Pain Pathway